Siteman Cancer Center awarded $7.8 million to expand clinical trials access
Physicians at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis have been awarded a six-year, $7.8 million grant from the National Cancer Institute (NCI) to play a leading role in designing, conducting and enrolling patients in clinical trials through the NCI’s National Clinical Trials Network.
Finnish people’s unique genetic makeup offers clues to disease
A study of the genetics of the people of Finland, conducted in part by researchers at the School of Medicine, has revealed new clues to common diseases.
Goal-oriented rehab improves recovery in older adults
Researchers at the School of Medicine have found that Enhanced Medical Rehabilitation, a type of goal-oriented therapy, helps older patients recover more fully than standard physical or occupational therapy. It involves focusing on specific goals important to individual patients and motivating patients to work toward those goals during every therapy session.
Genes linked to death from sepsis ID’d in mice
Bacteria in the bloodstream can trigger an overwhelming immune response that causes sepsis, a life-threatening condition. Now, researchers at Washington University School of Medicine in St. Louis have found genes that help protect the body’s cells from dying during sepsis, which could lead to new treatments.
More cancer patients get help to quit smoking
A new program funded through the Cancer Moonshot Initiative has doubled the number of patients at Siteman Cancer Center assessed for smoking — and increased by fivefold the percentage of cancer patients who smoke now taking medication to help them quit. The results have been published in the journal Translational Behavioral Medicine.
For malnourished children, new therapeutic food boosts gut microbes, healthy development
Researchers at the School of Medicine and the International Centre for Diarrhoeal Disease Research in Dhaka, Bangladesh, are developing a new approach to address childhood malnutrition. They are designing therapeutic foods aimed at repairing the gut microbiomes of malnourished children.
Fighting pancreatic cancer with immunotherapy
Researchers at the School of Medicine in St. Louis and Rush University in Chicago have found a compound that promotes a vigorous immune assault on pancreatic cancer. The findings, in mice, suggest a way to improve immunotherapy for the deadly disease in patients.
Theater production explores wonders of human brain
Two nationally renowned neurosurgeons at the School of Medicine will present BrainWorks, a live theatrical performance that explores the wonders of the human brain by dramatizing real-life neurological cases. The performance, comprised of four one-act plays, will debut July 19-21.
Flatlining
Race, Work, and Health Care in the New Economy
African American health care workers are there for a reason. A new book by a Washington University in St. Louis social scientist shows how hospitals, clinics and other institutions participate in “racial outsourcing,” relying heavily on black doctors, nurses, technicians and physician assistants to do “equity work” — extra labor that makes organizations and their services […]
Understanding how tics are suppressed may help some at risk for tic disorders
Studying children shortly after they began experiencing tics, researchers at the School of Medicine discovered that although tics don’t go away, most children are able to suppress and control them. Understanding how they do that may provide insight to help others at risk for significant tic disorders.
Older Stories